Skip to main content
Clinical Trials/JPRN-UMIN000053143
JPRN-UMIN000053143
Not yet recruiting
未知

Evaluation of effects induced by ingesting test foods on energy expenditure at rest. - Evaluation of effects induced by ingesting test foods on energy expenditure at rest.

CPCC Company Limited.0 sites20 target enrollmentDecember 18, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy male adults
Sponsor
CPCC Company Limited.
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2023
End Date
September 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
CPCC Company Limited.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Subjects who have a habit of exercises. (2\) Subjects who can not brethe naturally using an aeromonitor. (3\) with irregular life rhythm (e.g., irregular shift work). (4\) Subjects having habitual alcohol intake. (5\) Subjects having a habit of smoking. (6\) Subjects having irregular eating habits. (7\) Subjects with dieting or planning to diet during this study. (8\) Subjects having serious allergic rhinitis. (9\) Subjects having severe anemia (10\) Subjects who have experience illness or deterioration of physical condition due to blood sampling in the past. (11\) Subjects who have difficulty in having blood drawn from a peripheral blood vein. (12\) Subjects who have periodically used health\-specific / functional / health foods including supplements, which might affect energy metabolism. (13\) Subjects who take affecting medicines (except nonaffecting painkiller/antiinflamentry/external/eyedrops) within a month before the consent. (14\) Subjects with a maximal blood pressure of less than 90 mmHg. (15\) Subjects who donated their blood components and/or whole blood (0\.2 L) within the past 4 weeks. (16\) Subjects who donated their whole blood (0\.4 L) within the past 12 weeks. (17\) Subjects being collected in total of their blood (1\.2 L) within the past 12 months and in this research. (18\) Subjects being under other clinical tests, or partook in those within the past four weeks, or will join those after the consent. (19\) Subjects who meet any of the following: (a) suffering from heart, liver, or kidney disease (including complications of other diseases) (b) having a history of cardiovascular disease (c) diabetes (d) allergic to the test food and required one. (20\) Others who were judged as inappropriate for participation by the principal/sub investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials